Utama › Kanser Metastatik
Kajian klinikal Kanser Metastatik sedang mengambil peserta di AS
283 kajian untuk Kanser Metastatik sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX104 kajian
- New York City, NY93 kajian
- Nashville, TN70 kajian
- Boston, MA63 kajian
- Los Angeles, CA57 kajian
- St. Louis, MO54 kajian
- Arlington, VA53 kajian
- Philadelphia, PA46 kajian
- Chicago, IL45 kajian
- San Antonio, TX44 kajian
- Washington, DC43 kajian
- Dallas, TX42 kajian
- Seattle, WA39 kajian
- Durham, NC33 kajian
- Rochester, MN31 kajian
- Pittsburgh, PA31 kajian
- Baldwin Park, CA30 kajian
- Cleveland, OH30 kajian
- San Diego, CA30 kajian
- Tampa, FL29 kajian
- Orlando, FL29 kajian
- Denver, CO29 kajian
- Portland, OR29 kajian
- Atlanta, GA28 kajian
- Queens, NY28 kajian
- San Francisco, CA28 kajian
- Baltimore, MD28 kajian
- Jacksonville, FL28 kajian
- Columbus, OH27 kajian
- Aurora, CO25 kajian
- Mountain View, CA25 kajian
- Detroit, MI24 kajian
- Miami, FL24 kajian
- New Haven, CT23 kajian
- Grand Rapids, MI22 kajian
- Madison, WI21 kajian
- Salt Lake City, UT20 kajian
- Phoenix, AZ20 kajian
- Edison, NJ20 kajian
- Orange, CA20 kajian
Mengikut negeri
- Alabama13 kajian
- Arizona46 kajian
- Arkansas14 kajian
- California130 kajian
- Colorado50 kajian
- Connecticut27 kajian
- Delaware8 kajian
- Florida91 kajian
- Georgia34 kajian
- Hawaii5 kajian
- Idaho5 kajian
- Illinois58 kajian
- Indiana25 kajian
- Iowa10 kajian
- Kansas15 kajian
- Kentucky17 kajian
- Louisiana20 kajian
- Maine9 kajian
- Maryland47 kajian
- Massachusetts65 kajian
- Michigan51 kajian
- Minnesota40 kajian
- Mississippi6 kajian
- Missouri59 kajian
- Montana4 kajian
- Nebraska15 kajian
- Nevada10 kajian
- New Hampshire11 kajian
- New Jersey44 kajian
- New Mexico13 kajian
- New York111 kajian
- North Carolina52 kajian
- North Dakota5 kajian
- Ohio62 kajian
- Oklahoma16 kajian
- Oregon29 kajian
- Pennsylvania68 kajian
- Rhode Island9 kajian
- South Carolina14 kajian
- South Dakota10 kajian
- Tennessee75 kajian
- Texas139 kajian
- Utah31 kajian
- Vermont4 kajian
- Virginia66 kajian
- Washington47 kajian
- West Virginia6 kajian
- Wilayah Columbia24 kajian
- Wisconsin34 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07562152Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
Mengambil peserta
Umur 15 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07856394Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05372614A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06270706A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07205822A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06234605A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 19 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06586957A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07213817TLR9 Immunotherapy for Peritoneal Carcinomatosis
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07658196Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05287945Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06625775SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05222620PRE-ISPY Phase I/II Oncology Platform Program
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05868226A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07085091A Study of ASP3082 in Adults With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05382559First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05875168Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06943755Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05803382Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07222800A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277413Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05059678A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Mengambil pesertaFasa 1/2
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04094610Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.